All Stories

  1. Artificial intelligence driven protein design and sustainable nanomedicine for advanced theranostics
  2. Photobiomodulation Therapy in the Management of Orofacial Neuropathic Pain—WALT Position Paper 2026
  3. Advanced strategies for extending the blood circulation time of nano-based delivery systems
  4. When the victim becomes the villain: Platelets as drivers of immune dysregulation in ITP
  5. Distinguishing amyotrophic lateral sclerosis from radiculopathy using machine learning to analyze nerve conduction data
  6. Enhanced killing of ocular melanoma cells by combining femtosecond laser light with laser-ablated CuO nanoparticles
  7. Femtosecond laser irradiation has an anti-virulence effect by reducing the adhesion and invasion of MRSA bacteria to human cells: an in vitro study
  8. Exploring the role of miR-221/222 in gastrointestinal cancers: implications for innovative therapeutic strategies
  9. Biomaterials for CNS disorders: a review of development from traditional methods to AI-assisted optimization
  10. Effects of Photobiomodulation on Nervous System Disorders: A Narrative Review
  11. A Lipid with Lewis Pair‐Mediated Targeting and Multiple Stimuli‐Responsive Delivery of Antibiotics for Bacterial Infections
  12. Effect of light-emitting diode photobiomodulation on rat liver metabolomics after streptozotocin-induced diabetes – an evidence from nuclear magnetic resonance spectroscopy
  13. Nanodrug-based modulation of platelet–leukocyte interactions in ovarian cancer: a new frontier in targeted therapy
  14. Synthesis of 5-Fluorouracil (5-FU) coated platinum nanoparticles and apoptotic effects on U87 human glioblastoma cells
  15. Self-replicating nanomaterials as a new generation of smart nanostructures
  16. Cover Image: Volume 57 Issue 5
  17. Advanced drug delivery platforms target cancer stem cells
  18. The dual role of chaperone-mediated autophagy in the response and resistance to cancer immunotherapy
  19. Apigenin's Influence on Inflammatory and Epigenetic Responses in Rat Lungs After Radiotherapy
  20. Micro‐Focused Ultrasound Technology for Remodeling of Skin Tissue Architecture in an Animal Model
  21. The Role of Artificial Intelligence in Photomedicine
  22. Synergistic effect of NO and reactive oxygen species as a new approach in PDT: Photobiological and biochemical studies involving phthalocyanine-ruthenium complexes as new photosensitizer
  23. Gut microbiota modulation: a key determinant of atopic dermatitis susceptibility in children
  24. Conditioned Medium Treatment for the Improvement of Functional Recovery after Spinal Cord Injury: A Meta-Analysis Study
  25. The effects of peptide IF7-conjugated dendrimer loaded with doxorubicin on colorectal cancer
  26. The effect of melatonin administration on motor recovery after spinal cord injury in animal models: a systematic review and meta-analysis
  27. Effects of transcranial photobiomodulation on fine motor skills in boccia para‐athletes
  28. Metal-Coordinated Histidine-Functionalized Redox-Responsive Polyethyleneimine as a Smart Gene Delivery Vector
  29. Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM dendrimer for improvement of the therapeutic efficacy in cervical cancer
  30. Functional Recovery Promotion After Spinal Cord Injury With Astaxanthin Treatment in Preclinical Studies: A Systematic Review and Meta‐Analysis
  31. 4‐Methylumbelliferone (4‐MU) Improves Learning and Memory After Cerebral Ischemia/Reperfusion Injury in Rats
  32. Antimicrobial carbon materials-based quantum dots: From synthesis strategies to antibacterial properties for diagnostic and therapeutic applications in wound healing
  33. Regulatory role of microRNAs in virus-mediated inflammation
  34. Clinical aPDT's effect on Candida albicans: Antifungal susceptibility, virulence gene expression, and correlation with leukocyte and neutrophil counts
  35. CircRNAs as a Novel Class of Potential Diagnostic Biomarkers in Bipolar Disorders
  36. Green Synthesis of Au-Doped Tin Oxide Nanoparticles Using Teucrium Polium Extract with Potential Applications in Photodynamic Therapy
  37. Nucleic acid-responsive smart systems for controlled cargo delivery
  38. Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia
  39. What is the potential of antibacterial, antiviral and antifungal photodynamic therapy in dentistry?
  40. Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection
  41. Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide
  42. Rose Bengal diacetate-mediated antimicrobial photodynamic inactivation: potentiation by potassium iodide and acceleration of wound healing in MRSA-infected diabetic mice
  43. A structural and biochemical approach to effect of temperature and pH on the Molten Globule phenomenon in a thermophilic protease: Molecular dynamics simulation, fluorescence spectroscopy and circular dichroism
  44. Correction to “Activation of testosterone‐androgen receptor mediates cerebrovascular protection by photobiomodulation treatment in photothrombosis‐induced stroke rats”
  45. Correction to: Photobiomodulation preconditioned diabetic adipose derived stem cells with additional photobiomodulation: an additive approach for enhanced wound healing in diabetic rats with a delayed healing wound
  46. Proteases, a powerful biochemical tool in the service of medicine, clinical and pharmaceutical
  47. Combinations of Energy‐based Devices plus isotretinoin for management of acne and acne scars: A systematic review
  48. A spotlight on dosage and subject selection for effective neuroprotection: exploring the central role of mitochondria
  49. Development of a novel nanoformulation based on aloe vera-derived carbon quantum dot and chromium-doped alumina nanoparticle (Al2O3:Cr@Cdot NPs): evaluating the anticancer and antimicrobial activities of nanoparticles in photodynamic therapy
  50. Photobiomodulation Treatment with a Home-Use Device for COVID-19: A Randomized Controlled Trial for Efficacy and Safety
  51. Studying the viability and growth kinetics of vancomycin-resistant Enterococcus faecalis V583 following femtosecond laser irradiation (420–465 nm)
  52. Photobiomodulation in experimental models of Alzheimer’s disease: state-of-the-art and translational perspectives
  53. Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: From mechanisms to therapy
  54. Effects of Low-Level Light Therapy on Resting-State Connectivity Following Moderate Traumatic Brain Injury: Secondary Analyses of a Double-blinded Placebo-controlled Study
  55. Assessing the Effects of Curcumin and 450 nm Photodynamic Therapy on Oxidative Metabolism and Cell Cycle in Head and Neck Squamous Cell Carcinoma: An In Vitro Study
  56. Photobiomodulation preconditioned diabetic adipose derived stem cells with additional photobiomodulation: an additive approach for enhanced wound healing in diabetic rats with a delayed healing wound
  57. Use of the traditional Chinese medicine “compound healthy ear agent” to protect against age-related hearing loss in mice: A proteomics study
  58. Doxorubicin-loaded zymosan nanoparticles: Synergistic cytotoxicity and modulation of apoptosis and Wnt/β-catenin signaling pathway in C26 colorectal cancer cells
  59. Pyroptosis and the tumor immune microenvironment: A new battlefield in ovarian cancer treatment
  60. Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy
  61. Histological evaluation of monopolar and bipolar radiofrequency microneedling treatment in a porcine model
  62. Activation of testosterone‐androgen receptor mediates cerebrovascular protection by photobiomodulation treatment in photothrombosis‐induced stroke rats
  63. Comparison of 755‐nm picosecond alexandrite laser versus 1064‐nm Q‐switched Nd:YAG laser for melasma: A randomized, split‐face controlled, 2‐year follow‐up study
  64. Photobiomodulation therapy (red/NIR LEDs) reduced the length of stay in intensive care unit and improved muscle function: A randomized, triple‐blind, and sham‐controlled trial
  65. Editorial: Photobiomodulation and phototherapy in skin diseases
  66. Effects of Electrospun Nanofibers on Motor Function Recovery After Spinal Cord Injury: A Systematic Review and Meta-Analysis
  67. Retraction: Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide
  68. Die Bedeutung von Mikrokomedonen bei der Akne: Von der Beschreibung bis zum Behandlungsansatz?
  69. The role of microcomedones in acne: Moving from a description to treatment target?
  70. In-silico characterization of a thermophilic serine protease via homology modeling, docking and molecular dynamics simulations
  71. Transcranial photobiomodulation mitigates learning and memory impairments induced by hindlimb unloading in a mouse model of microgravity exposure by suppression of oxidative stress and neuroinflammation signaling pathways
  72. Expression of selected long non-coding RNAs in gastric cancer cells treated with coumarin: Possible mechanisms for anti-cancer activity
  73. Combination of anti-miR19a-3p polyplex plus doxorubicin for breast cancer in 2D culture and apoptosis assay in 3D spheroids in a microwell device
  74. In vitro study: green synthesis and evaluation of MgO/C-dots/DOX phosphorescent nanocomposites for photodynamic/photocatalytic therapy of tumors
  75. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools
  76. A Phase 1 randomized, open‐label clinical trial to evaluate the effect of a far‐infrared emitting patch on local skin perfusion, microcirculation and oxygenation
  77. The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer
  78. Photodynamic therapy in cancer stem cells — state of the art
  79. Recent advances in 3D bioprinted tumor models for personalized medicine
  80. Molecular targets, therapeutic agents and multitasking nanoparticles to deal with cancer stem cells: A narrative review
  81. Nanoarchitecture-based photothermal ablation of cancer: A systematic review
  82. Comparison between local abdominal and transcutaneous tail vein photobiomodulation in experimental rat model of ulcerative colitis
  83. Disseminated disease caused by Mycobacterium marseillense: A case report and literature review
  84. Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers
  85. Microbial Phytases: Properties and Applications in the Food Industry
  86. MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis
  87. Phenylalanine-Arginine-β-Naphthylamide Enhances the Photobactericidal Effect of Methylene Blue on Pseudomonas aeruginosa
  88. Emerging roles of miR-145 in gastrointestinal cancers: A new paradigm
  89. Future Nanotechnology‐Based Strategies for Improved Management of Helicobacter pylori Infection
  90. MiRNA-related metastasis in oral cancer: moving and shaking
  91. Editorial: Physical therapy in the treatment of skin diseases and its mechanism
  92. Non-coding RNAs and exosomal non-coding RNAs in pituitary adenoma
  93. Transcranial photobiomodulation for the brain: a wide range of clinical applications
  94. Contact dermatitis caused by prevention measures during the COVID-19 pandemic: a narrative review
  95. Could probiotics protect against human toxicity caused by polystyrene nanoplastics and microplastics?
  96. Mechanism and antibacterial synergies of poly(Dabco-BBAC) against multi-drug resistant Pseudomonas aeruginosa isolates from human burns
  97. Dose and time–response effect of photobiomodulation therapy on glycemic control in type 2 diabetic patients combined or not with hypoglycemic medicine: A randomized, crossover, double‐blind, sham‐controlled trial
  98. Combined Use of Photobiomodulation and Curcumin-Loaded Iron Oxide Nanoparticles Significantly Improved Wound Healing in Diabetic Rats Compared to Either Treatment Alone
  99. Influence of nitro ruthenium isomerization on photochemically induced nitric oxide release: Vasorelaxant activities
  100. Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
  101. Protein-protected metal nanoclusters as diagnostic and therapeutic platforms for biomedical applications
  102. Resveratrol in Cancer Treatment with a Focus on Breast Cancer
  103. Photobiomodulation, alone or combined with adipose-derived stem cells, reduces inflammation by modulation of microRNA-146a and interleukin-1ß in a delayed-healing infected wound in diabetic rats
  104. Photobiomodulation Therapy for Muscular Dystrophy: Time for a Trial?
  105. Role of non-coding RNAs in neuroblastoma
  106. Fiat Lux: Light and Pedagogy for the 21st Century
  107. Generation of magnetic biohybrid microrobots based on MSC.sTRAIL for targeted stem cell delivery and treatment of cancer
  108. Apoptosis and myocardial infarction: role of ncRNAs and exosomal ncRNAs
  109. Insights into Photobiomodulation and Oxidative Stress: Physiological, Pathological, and Therapeutic Impact
  110. Author Correction: Study of nerve cell regeneration on nanofibers containing cerium oxide nanoparticles in a spinal cord injury model in rats
  111. Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal against Helicobacter pylori
  112. Biochemical and molecular characterization of novel keratinolytic protease from Bacillus licheniformis (KRLr1)
  113. Time-dependent photobiomodulation management of neuropathic pain induced by spinal cord injury in male rats
  114. Photobiomodulation for Skin Pigmentation Disorders: A Dual-Function Treatment
  115. Exosomes released from U87 glioma cells treated with curcumin and/or temozolomide produce apoptosis in naive U87 cells
  116. Silica NPs–Cytotoxicity Cross-Talk: Physicochemical Principles and Cell Biology Responses
  117. Non-coding RNAs and Exosomal Non-coding RNAs in Traumatic Brain Injury: the Small Player with Big Actions
  118. In silico design and immunoinformatics analysis of a chimeric vaccine construct based on Salmonella pathogenesis factors
  119. Antibacterial effects in blood irradiated with a polychromatic device mediated through reactive oxygen species: possible involvement of haem
  120. Could Photobiomodulation Be Incorporated into Indoor Lighting?
  121. Intravascular laser irradiation of blood (ILIB) used to treat lung diseases: a short critical review
  122. Receptor tyrosine kinase inhibitors in cancer
  123. Nanodelivery systems for cutaneous melanoma treatment
  124. Mitochondrial Transplantation: Could Photobiomodulation Play a Role?
  125. Study of nerve cell regeneration on nanofibers containing cerium oxide nanoparticles in a spinal cord injury model in rats
  126. Correction to “Turning Toxic Nanomaterials into a Safe and Bioactive Nanocarrier for Co-delivery of DOX/pCRISPR”
  127. Application of nano‐radiosensitizers in combination cancer therapy
  128. Role of the skin microbiota and intestinal microbiome in rosacea
  129. Effects of multiwavelength photobiomodulation for the treatment of traumatic soft tissue injuries associated with bone fractures: A double‐blind, randomized controlled clinical trial
  130. Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance
  131. Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis
  132. Transcranial Photobiomodulation Treatment: Significant Improvements in Four Ex-Football Players with Possible Chronic Traumatic Encephalopathy
  133. Could Photobiomodulation Therapy Be Helpful in Epilepsy?
  134. An update on fractional picosecond laser treatment: histology and clinical applications
  135. Role of opsins and light or heat activated transient receptor potential ion channels in the mechanisms of photobiomodulation and infrared therapy.
  136. Photobiomodulation Therapy for Treatment of Extravasation Injuries in Cancer Chemotherapy
  137. Effects of photobiomodulation on mitochondrial function in diabetic adipose-derived stem cells in vitro
  138. Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer
  139. Prospects for hypoxia-based drug delivery platforms for the elimination of advanced metastatic tumors: From 3D modeling to clinical concepts
  140. Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression
  141. Impact of Blue Light Therapy on Wound Healing in Preclinical and Clinical Subjects: A Systematic Review
  142. Role of Polarized Light in Photobiomodulation
  143. Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?
  144. Neutrophil mediated drug delivery for targeted glioblastoma therapy: A comprehensive review
  145. Non-coding RNAs and glioma: Focus on cancer stem cells
  146. Epigenetic regulation in myocardial infarction: Non-coding RNAs and exosomal non-coding RNAs
  147. Extracellular vesicles biogenesis, isolation, manipulation and genetic engineering for potential in vitro and in vivo therapeutics: An overview
  148. Transcriptomic and proteomic profile approaches toward drought and salinity stresses
  149. Do Biophotons Play Any Role in Transcranial Photobiomodulation of the Brain?
  150. Correlations between single nucleotide polymorphisms in obsessive-compulsive disorder with the clinical features or response to therapy
  151. A designed peptide-based vaccine to combat Brucella melitensis, B. suis and B. abortus: Harnessing an epitope mapping and immunoinformatics approach
  152. Stem cell membrane-coated abiotic nanomaterials for biomedical applications
  153. Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer
  154. Sustained delivery of chABC improves functional recovery after a spine injury
  155. MicroRNA-383: A tumor suppressor miRNA in human cancer
  156. Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment
  157. Applications of resveratrol in the treatment of gastrointestinal cancer
  158. Traditional or Infrared Saunas and Photobiomodulation: What Do They Have in Common?
  159. Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
  160. Structure and functions of Aggregation-Induced Emission-Photosensitizers in anticancer and antimicrobial theranostics
  161. Very Low-Level Transcranial Photobiomodulation for Major Depressive Disorder
  162. Saponin and fluorine-modified polycation as a versatile gene delivery system
  163. Aspects of Antiviral Strategies Based on Different Phototherapy Approaches: Hit by the Light
  164. Phototherapy-Based Treatment for Sexually Transmitted Infections—Shining Light into Unexplored Territory
  165. Optimization of the Duration and Dose of Photobiomodulation Therapy (660 nm Laser) for Spinal Cord Injury in Rats
  166. Photobiomodulation for Gulf War Illness?
  167. Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications
  168. Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers
  169. Evidence for the Benefits of Melatonin in Cardiovascular Disease
  170. Home-use Photobiomodulation Device Treatment Outcomes for COVID-19
  171. Hyaluronic Acid-Based Nanomaterials as a New Approach to the Treatment and Prevention of Bacterial Infections
  172. MicroRNAs and Synaptic Plasticity: From Their Molecular Roles to Response to Therapy
  173. Could Photobiomodulation Treat Autism Spectrum Disorder?
  174. Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy
  175. Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
  176. Physical properties and biological effects of ceramic materials emitting infrared radiation for pain, muscular activity, and musculoskeletal conditions
  177. An update on Becker's nevus: Pathogenesis and treatment
  178. The potential of curcumin for treating spinal cord injury: a meta-analysis study
  179. Effects of microRNAs and long non-coding RNAs on chemotherapy response in glioma
  180. Neuronal differentiation potential of primary and immortalized adipose stem cells by photobiomodulation
  181. Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
  182. Injection of Cerium Oxide Nanoparticles to Treat Spinal Cord Injury in Rats
  183. Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity
  184. Safety of 222 nm UVC Irradiation to the Surgical Site in a Rabbit Model
  185. Application of Quercetin in the Treatment of Gastrointestinal Cancers
  186. Role of the Bone Marrow Microenvironment in Drug Resistance of Hematological Malignances
  187. Photobiomodulation and Stem Cell on Repair of Osteoporotic Bones
  188. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy
  189. Nanomaterials for photothermal and photodynamic cancer therapy
  190. Non-coding RNAs and glioblastoma: Insight into their roles in metastasis
  191. Rapid monitoring of serum albumin as a biomarker of liver and kidney diseases using femtosecond laser-induced fluorescence
  192. Histidine‐enhanced gene delivery systems: The state of the art
  193. Platinum Nanoparticles in Biomedicine: Preparation, Anti-Cancer Activity, and Drug Delivery Vehicles
  194. Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies
  195. MicroRNA let-7 and viral infections: focus on mechanisms of action
  196. Antibacterial, antibiofilm, anti-inflammatory, and wound healing effects of nanoscale multifunctional cationic alternating copolymers
  197. Photobiomodulation Therapy Mechanisms Beyond Cytochrome c Oxidase
  198. Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma
  199. RdRp inhibitors and COVID-19: Is molnupiravir a good option?
  200. Smart Strategies for Precise Delivery of CRISPR/Cas9 in Genome Editing
  201. Non-Coding RNAs and Brain Tumors: Insights Into Their Roles in Apoptosis
  202. Potential of natural products in the treatment of myocardial infarction: focus on molecular mechanisms
  203. Cell cycle involvement in cancer therapy; WEE1 kinase, a potential target as therapeutic strategy
  204. Gold nanostructures: synthesis, properties, and neurological applications
  205. Targeting the metabolism of cancer stem cells by energy disruptor molecules
  206. Anti‐inflammatory and Immunomodulatory Properties of Lepidium sativum
  207. Near-infrared photoimmunotherapy: design and potential applications for cancer treatment and beyond
  208. Physiological, biochemical, and metabolic responses of abiotic plant stress: salinity and drought
  209. Photodynamic therapy for squamous cell carcinoma of the head and neck: narrative review focusing on photosensitizers
  210. 3D bioprinting technology to mimic the tumor microenvironment: tumor-on-a-chip concept
  211. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers
  212. Improved wound healing of diabetic foot ulcers using human placenta-derived mesenchymal stem cells in gelatin electrospun nanofibrous scaffolds plus a platelet-rich plasma gel: A randomized clinical trial
  213. MicroRNA-155 and antiviral immune responses
  214. Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms
  215. The effect of photobiomodulation therapy on antioxidants and oxidative stress profiles of adipose derived mesenchymal stem cells in diabetic rats
  216. Smart arginine-equipped polycationic nanoparticles for p/CRISPR delivery into cells
  217. Cellulose-Based Nanofibril Composite Materials as a New Approach to Fight Bacterial Infections
  218. Beneficial effects of infrared light-emitting diode in corticosteroid-resistant asthma
  219. Polylysine for skin regeneration: A review of recent advances and future perspectives
  220. Local (but not systemic) photobiomodulation treatment reduces mast cell degranulation, eicosanoids, and Th2 cytokines in an experimental model of allergic rhinitis
  221. Polyethylenimine-Functionalized Carbon Dots for Delivery of CRISPR/Cas9 Complexes
  222. Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
  223. Editorial: Antimicrobial Photodynamic Therapy: A New Paradigm in the Fight Against Infections
  224. The potential application of organoids in breast cancer research and treatment
  225. Review of Oxygenation with Nanobubbles: Possible Treatment for Hypoxic COVID-19 Patients
  226. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
  227. Photobiomodulation Enhances Memory Processing in Older Adults with Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy Study
  228. Photobiomodulation Therapy for Dementia: A Systematic Review of Pre-Clinical and Clinical Studies
  229. Pilot Study on Dose-Dependent Effects of Transcranial Photobiomodulation on Brain Electrical Oscillations: A Potential Therapeutic Target in Alzheimer’s Disease
  230. Photobiomodulation of the Brain: Shining Light on Alzheimer’s and Other Neuropathological Diseases
  231. Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?
  232. Applications of scaffold-based advanced materials in biomedical sensing
  233. Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum]
  234. COVID-19 in patients with cancer: Risks and precautions
  235. Diagnostic and drug release systems based on microneedle arrays in breast cancer therapy
  236. Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer
  237. Roles of Non-coding RNAs and Angiogenesis in Glioblastoma
  238. Distribution of gold nanoparticles into the brain: a systematic review and meta-analysis
  239. Electroconductive multi-functional polypyrrole composites for biomedical applications
  240. Long Noncoding RNAs CAT2064 and CAT2042 may Function as Diagnostic Biomarkers for Prostate Cancer by Affecting Target MicrorRNAs
  241. Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications
  242. Alginate scaffolds improve functional recovery after spinal cord injury
  243. Effect of Celliant® armbands on grip strength in subjects with chronic wrist and elbow pain: randomized double-blind placebo-controlled trial
  244. Emerging role of nanoclays in cancer research, diagnosis, and therapy
  245. Radiolabeled carbon-based nanostructures: New radiopharmaceuticals for cancer therapy?
  246. A randomized, controlled, split‐face study of topical timolol maleate 0.5% eye drops for the treatment of erythematotelangiectatic rosacea
  247. Bioinspired hydrogels build a bridge from bench to bedside
  248. Dysregulated expression of miRNAs in immune thrombocytopenia
  249. Functionalized magnetic nanoparticles for the separation and purification of proteins and peptides
  250. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies
  251. The effect of femtosecond laser irradiation on the growth kinetics of Staphylococcus aureus: An in vitro study
  252. Neurotoxicity of silver nanoparticles in the animal brain: a systematic review and meta-analysis
  253. Hybrid Bionanocomposite Containing Magnesium Hydroxide Nanoparticles Embedded in a Carboxymethyl Cellulose Hydrogel Plus Silk Fibroin as a Scaffold for Wound Dressing Applications
  254. Development of neoantigens: from identification in cancer cells to application in cancer vaccines
  255. Advanced Bioresponsive Multitasking Hydrogels in the New Era of Biomedicine
  256. Interplay between SOX9 transcription factor and microRNAs in cancer
  257. Photoneuromodulation makes a difficult cognitive task less arduous
  258. Plant-based vaccines and cancer therapy: Where are we now and where are we going?
  259. Turning Toxic Nanomaterials into a Safe and Bioactive Nanocarrier for Co-delivery of DOX/pCRISPR
  260. Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
  261. Angiogenesis-related non-coding RNAs and gastrointestinal cancer
  262. Cell death pathways and viruses: Role of microRNAs
  263. Antimicrobial photodynamic therapy for oral Candida infection in adult AIDS patients: A pilot clinical trial
  264. Green chemistry and coronavirus
  265. Long non-coding RNAs in the doxorubicin resistance of cancer cells
  266. Non-coding RNAs related to angiogenesis in gynecological cancer
  267. Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
  268. The role of SOX family transcription factors in gastric cancer
  269. Transcranial photobiomodulation prevents PTSD-like comorbidities in rats experiencing underwater trauma
  270. Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy
  271. Digital Transformation of Photobiomodulation Therapy: A Step Forward to Become Mainstream?
  272. Effect of Transcranial Low-Level Light Therapy Among Patients With Moderate Traumatic Brain Injury
  273. Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19
  274. Low‐dose photodynamic therapy effect on closure of scratch wounds of normal and diabetic fibroblast cells: An in vitro study
  275. Immune checkpoint inhibition in classical hodgkin lymphoma
  276. Photobiomodulation prevents PTSD-like memory impairments in rats
  277. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers
  278. Streptococcal bacterial components in cancer therapy
  279. Chitosan-Based Nanoparticles Against Viral Infections
  280. Effects of the phenotypic polarization state of human leukocytes on the optical absorbance spectrum
  281. A preliminary clinical trial comparing wet silver dressings versus wet‐to‐dry povidone‐iodine dressings for wound healing in pemphigus vulgaris patients
  282. Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches
  283. Carbon Nanotubes: Smart Drug/Gene Delivery Carriers
  284. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators
  285. Mechanistic aspects of photobiomodulation therapy in the nervous system
  286. Ki-67 expression as a diagnostic biomarker in odontogenic cysts and tumors: A systematic review and meta-analysis
  287. Infrared radiation from cage bedding moderates rat inflammatory and autoimmune responses in collagen-induced arthritis
  288. Applications of advanced materials in bio-sensing in live cells: Methods and applications
  289. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers
  290. Development of a graphene oxide-poly lactide nanocomposite as a Smart Drug Delivery System
  291. Electrospraying as a novel method of particle engineering for drug delivery vehicles
  292. Transcranial Photobiomodulation to Improve Cognition in Gulf War Illness
  293. The Photosensitizing Efficacy of Micelles Containing a Porphyrinic Photosensitizer and KI against Resistant Melanoma Cells
  294. The Influence of Some Axial Ligands on Ruthenium–Phthalocyanine Complexes: Chemical, Photochemical, and Photobiological Properties
  295. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance
  296. Effects of therapeutic probiotics on modulation of microRNAs
  297. Approaches for the integration of big data in translational medicine: single‐cell and computational methods
  298. The colorful world of carotenoids: a profound insight on therapeutics and recent trends in nano delivery systems
  299. Interdisciplinary Approaches to COVID-19
  300. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles
  301. Probable positive effects of the photobiomodulation as an adjunctive treatment in COVID-19: A systematic review
  302. Organic dots (O-dots) for theranostic applications: preparation and surface engineering
  303. Corrigendum to ‘5-Aza-2’-deoxycytidine potentiates antitumor immune response induced by photodynamic therapy’ [the Eur J Canc (2014) 1370–1381]
  304. Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view
  305. Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials
  306. Molecular beacon strategies for sensing purpose
  307. Photobiomodulation and Antiviral Photodynamic Therapy in COVID-19 Management
  308. Photodynamic therapy accelerates skin wound healing through promoting re-epithelialization
  309. The Toxic Effect of Silver Nanoparticles on Nerve Cells: A Systematic Review and Meta-Analysis
  310. Two long non-coding RNAs, CAT179 and CAT 1796, differentiate between benign prostate hyperplasia and prostate cancer
  311. Factors Affecting Photodynamic Therapy and Anti-Tumor Immune Response
  312. Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications
  313. Comparison of Fractional Micro‐Plasma Radiofrequency and Fractional Microneedle Radiofrequency for the Treatment of Atrophic Acne Scars: A Pilot Randomized Split‐Face Clinical Study in China
  314. Innate lymphoid cell subsets and their cytokines in autoimmune diseases
  315. Multivalent nanomedicines to treat COVID-19: A slow train coming
  316. Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials
  317. Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect
  318. The effect of chondroitinase ABC and photobiomodulation therapy on neuropathic pain after spinal cord injury in adult male rats
  319. Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease
  320. The potential use of theranostic bacteria in cancer
  321. Recent progress in the design of DNA vaccines against tuberculosis
  322. Light-based technologies for management of COVID-19 pandemic crisis
  323. The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis
  324. Tumor cryotherapy using Ice-producing bacteria
  325. PIWI-interacting RNAs and PIWI proteins in glioma: molecular pathogenesis and role as biomarkers
  326. Photobiomodulation of avian embryos by red laser
  327. Nano-based delivery systems for berberine: A modern anti-cancer herbal medicine
  328. Carbosilane dendrimers: Drug and gene delivery applications
  329. Photobiomodulation for spinal cord injury: A systematic review and meta-analysis
  330. Stimulus-responsive sequential release systems for drug and gene delivery
  331. Metal‐based nanoparticles for bone tissue engineering
  332. Effect of Transcranial Low-Level Light Therapy vs Sham Therapy Among Patients With Moderate Traumatic Brain Injury
  333. Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages
  334. Potential Applications of Advanced Nano/Hydrogels in Biomedicine: Static, Dynamic, Multi‐Stage, and Bioinspired
  335. Autophagy-related MicroRNAs in chronic lung diseases and lung cancer
  336. Recent Developments in Graphene and Graphene Oxide: Properties, Synthesis, and Modifications: A Review
  337. COVID-19: Transmission, prevention, and potential therapeutic opportunities
  338. Combined therapy of adipose-derived stem cells and photobiomodulation on accelerated bone healing of a critical size defect in an osteoporotic rat model
  339. Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality
  340. Nanomicellar-curcumin exerts its therapeutic effects via affecting angiogenesis, apoptosis, and T cells in a mouse model of melanoma lung metastasis
  341. Non-coding RNAs and Exosomes: Their Role in the Pathogenesis of Sepsis
  342. Quantity does not equal quality: Scientific principles cannot be sacrificed
  343. The immune system and COVID-19: Friend or foe?
  344. The Use of Fluorescent Probes to Detect ROS in Photodynamic Therapy
  345. Mesenchymal Stem Cell Spheroids Embedded in an Injectable Thermosensitive Hydrogel: An In Situ Drug Formation Platform for Accelerated Wound Healing
  346. Cytokines and COVID-19: friends or foes?
  347. A Novel Treatment of Opioid Cravings With an Effect Size of .73 for Unilateral Transcranial Photobiomodulation Over Sham
  348. Transdermal delivery of topical lidocaine in a mouse model is enhanced by treatment with cold atmospheric plasma
  349. A randomized split‐face, investigator‐blinded study of a picosecond Alexandrite laser for post‐inflammatory erythema and acne scars
  350. Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis
  351. Nanovehicles for co-delivery of anticancer agents
  352. Circular RNAs: New Epigenetic Signatures in Viral Infections
  353. Corrigendum: Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia‐ischemia
  354. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways
  355. Applications of cold atmospheric plasma for transdermal drug delivery: a review
  356. Photobiomodulation for Alzheimer’s Disease: Translating Basic Research to Clinical Application
  357. Photobiomodulation‐Induced Differentiation of Immortalized Adipose Stem Cells to Neuronal Cells
  358. Autophagy in cancers including brain tumors: role of MicroRNAs
  359. TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus
  360. Corrigendum to “Potassium iodide enhances the photobactericidal effect of methylene blue on Enterococcus faecalis as planktonic cells and as biofilm infection in teeth” [J Photochem Photobiol B 203(2020) 1–11/111730]
  361. Bioresorbable composite polymeric materials for tissue engineering applications
  362. The urgent need for integrated science to fight COVID-19 pandemic and beyond
  363. A powerful combination of copper-cysteamine nanoparticles with potassium iodide for bacterial destruction
  364. Controlled Gene Delivery Systems: Nanomaterials and Chemical Approaches
  365. Recent advances in nanotechnology-based drug delivery systems for the kidney
  366. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review
  367. Photobiomodulation for Parkinson’s Disease in Animal Models: A Systematic Review
  368. Successful treatment of polymorphic light eruption with UVA rush hardening: A report of 5 cases
  369. MicroRNAs and exosomes: key players in HIV pathogenesis
  370. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells
  371. Fluorescent light energy in wound healing: when is a photon something more?
  372. Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications
  373. Comparison of DNA and mRNA vaccines against cancer
  374. Combined effects of metformin and photobiomodulation improve the proliferation phase of wound healing in type 2 diabetic rats
  375. Exosomal miRNAs: novel players in viral infection
  376. Increased Functional Connectivity Within Intrinsic Neural Networks in Chronic Stroke Following Treatment with Red/Near-Infrared Transcranial Photobiomodulation: Case Series with Improved Naming in Aphasia
  377. Need for Caution When Applying Photobiomodulation Therapy for Hereditary Diseases
  378. Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy
  379. Recent advances in the application of mesoporous silica-based nanomaterials for bone tissue engineering
  380. Oxygen-Independent Antimicrobial Photoinactivation: Type III Photochemical Mechanism?
  381. Hyaluronic acid‐decorated liposomal nanoparticles for targeted delivery of 5‐fluorouracil into HT‐29 colorectal cancer cells
  382. Photobiomodulation plus Adipose-derived Stem Cells Improve Healing of Ischemic Infected Wounds in Type 2 Diabetic Rats
  383. Photodynamic Therapy for Cancer: What's Past is Prologue
  384. Efficient photodynamic inactivation of Candida albicans by porphyrin and potassium iodide co-encapsulation in micelles
  385. Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide
  386. Nanotechnology for angiogenesis: opportunities and challenges
  387. A Microneedling Fractional Radiofrequency Device for the Treatment of Nevus Comedonicus
  388. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role
  389. Drug efflux pumps in photodynamic therapy
  390. PAMAM Dendrimers as a Delivery System for Small Interfering RNA
  391. Potassium iodide enhances the photobactericidal effect of methylene blue on Enterococcus faecalis as planktonic cells and as biofilm infection in teeth
  392. Photobiomodulation therapy for management of inferior alveolar nerve injury post-extraction of impacted lower third molars
  393. Theranostic applications of stimulus-responsive systems based on carbon dots
  394. Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
  395. Bioengineering International joins the Family of Platinum Open Access Journals
  396. Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?
  397. Transcranial Near-Infrared Light: Dose-Dependent Effects on EEG Oscillations but not Cerebral Blood Flow
  398. Microfluidic devices with gold thin film channels for chemical and biomedical applications: a review
  399. miRNAs derived from cancer-associated fibroblasts in colorectal cancer
  400. “Photobiomics”: Can Light, Including Photobiomodulation, Alter the Microbiome?
  401. Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review
  402. Exploration of Copper-Cysteamine Nanoparticles as a New Type of Agents for Antimicrobial Photodynamic Inactivation
  403. Penetration Profiles of Visible and Near-Infrared Lasers and Light-Emitting Diode Light Through the Head Tissues in Animal and Human Species: A Review of Literature
  404. Potential Application of Upconverting Nanoparticles for Brain Photobiomodulation
  405. Reported Side Effects, Weight and Blood Pressure, After Repeated Sessions of Transcranial Photobiomodulation
  406. Transcranial Photobiomodulation Improves Cognitive Performance in Young Healthy Adults: A Systematic Review and Meta-Analysis
  407. Transcranial Photobiomodulation with Near-Infrared Light for Generalized Anxiety Disorder: A Pilot Study
  408. Differentiation of Mesenchymal Stem Cells to Neuroglia: in the Context of Cell Signalling
  409. Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives
  410. Tetracyclines: light-activated antibiotics?
  411. CFIm25 and alternative polyadenylation: Conflicting roles in cancer
  412. In vitro photodynamic therapy of endothelial cells using hematoporphyrin monomethyl ether (Hemoporfin): Relevance to treatment of port wine stains
  413. Photobiomodulation combined with photodynamic therapy using ruthenium phthalocyanine complexes in A375 melanoma cells: Effects of nitric oxide generation and ATP production
  414. The effects of photodynamic therapy with blue light and papain-based gel associated with Urucum, on collagen and fibroblasts: a spectroscopic and cytotoxicity analysis
  415. Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders
  416. Multimodal quantitative imaging of brain cancer in cultured cells
  417. Photobiomodulation for Alzheimer’s Disease: Has the Light Dawned?
  418. Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders
  419. Stimulus-responsive polymeric nanogels as smart drug delivery systems
  420. Carbon based nanomaterials for tissue engineering of bone: Building new bone on small black scaffolds: A review
  421. Applications of Photobiomodulation Therapy to Musculoskeletal Disorders and Osteoarthritis with Particular Relevance to Canada
  422. How to Write a Good Photobiomodulation Article
  423. Photodynamic therapy for cancer: Role of natural products
  424. S198. Effects of Transcranial Photobiomodulation With Near-Infrared Light on Sexual Dysfunction
  425. F85. Reported Side-Effects, Weight and Blood Pressure After Repeated Sessions of Transcranial Photobiomodulation
  426. Amphiphilic tetracationic porphyrins are exceptionally active antimicrobial photosensitizers: In vitro and in vivo studies with the free‐base and Pd‐chelate
  427. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
  428. Advances in detection of fastidious bacteria: From microscopic observation to molecular biosensors
  429. Biomedical applications of nanoflares: Targeted intracellular fluorescence probes
  430. Photobiomodulation and Coenzyme Q10 Treatments Attenuate Cognitive Impairment Associated With Model of Transient Global Brain Ischemia in Artificially Aged Mice
  431. Rapid Reversal of Cognitive Decline, Olfactory Dysfunction, and Quality of Life Using Multi-Modality Photobiomodulation Therapy: Case Report
  432. Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia‐ischemia
  433. Selective photobiomodulation for emotion regulation: model-based dosimetry study
  434. Fluorescence Polarization of Methylene Blue as a Quantitative Marker of Breast Cancer at the Cellular Level
  435. Corrigendum
  436. Effective treatment and decolonization of a dog infected with carbapenemase ( VIM ‐2)‐producing Pseudomonas aeruginosa using probiotic and photodynamic therapies
  437. Introduction to “Advances in Photodynamic Therapy 2018”
  438. A combination of photodynamic therapy and antimicrobial compounds to treat skin and mucosal infections: a systematic review
  439. Sodium nitrite potentiates antimicrobial photodynamic inactivation: possible involvement of peroxynitrate
  440. Under the spotlight: mechanisms of photobiomodulation concentrating on blue and green light
  441. Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation, and apoptosis
  442. Design, synthesis and photobiological activity of novel ruthenium phthalocyanine complexes
  443. Correction: Photobiomodulation: lasers vs. light emitting diodes?
  444. Correction to: Photobiomodulation with single and combination laser wavelengths on bone marrow mesenchymal stem cells: proliferation and differentiation to bone or cartilage
  445. Review of light parameters and photobiomodulation efficacy: dive into complexity
  446. Photobiomodulation improves the frontal cognitive function of older adults
  447. Novel pharmacotherapy for burn wounds: what are the advancements
  448. Inorganic Salts and Antimicrobial Photodynamic Therapy: Mechanistic Conundrums?
  449. Photodynamic therapy for rosacea in Chinese patients
  450. Surface treatment with non-thermal humid argon plasma as a treatment for allergic contact dermatitis in a mouse model
  451. Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial
  452. Antimicrobial Photodynamic Inactivation Mediated by Tetracyclines in Vitro and in Vivo: Photochemical Mechanisms and Potentiation by Potassium Iodide
  453. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities
  454. Early diagnosis of disease using microbead array technology: A review
  455. Effect of red light and near infrared laser on the generation of reactive oxygen species in primary dermal fibroblasts
  456. A preliminary study of fractional CO2 laser added to topical tacrolimus combined with 308 nm excimer lamp for refractory vitiligo
  457. Point-of-care microfluidic devices for pathogen detection
  458. Mitochondrial dynamics (fission and fusion) and collagen production in a rat model of diabetic wound healing treated by photobiomodulation: comparison of 904 nm laser and 850 nm light-emitting diode (LED)
  459. Photobiomodulation with single and combination laser wavelengths on bone marrow mesenchymal stem cells: proliferation and differentiation to bone or cartilage
  460. Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction
  461. Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets
  462. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
  463. Attaching NorA efflux pump inhibitors to methylene blue enhances antimicrobial photodynamic inactivation of Escherichia coli and Acinetobacter baumannii in vitro and in vivo
  464. Comparison of two functionalized fullerenes for antimicrobial photodynamic inactivation: Potentiation by potassium iodide and photochemical mechanisms
  465. Multiplexed microarrays based on optically encoded microbeads
  466. Comparison of thiocyanate and selenocyanate for potentiation of antimicrobial photodynamic therapy
  467. Can light-based approaches overcome antimicrobial resistance?
  468. Photobiomodulation, Photomedicine, and Laser Surgery: A New Leap Forward Into the Light for the 21st Century
  469. Non-mammalian Hosts and Photobiomodulation: Do All Life-forms Respond to Light?
  470. Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
  471. Targeting the mitochondrial VDAC in hepatocellular carcinoma using a polyclonal antibody-conjugated to a nitrosyl ruthenium complex
  472. Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work?
  473. Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections
  474. Can 3D imaging provide insights into spatial variations in bacterial infection patterns?
  475. Pain management using photobiomodulation: Mechanisms, location, and repeatability quantified by pain threshold and neural biomarkers in mice
  476. Tetracyclines function as dual-action light-activated antibiotics
  477. Antimicrobial photodynamic therapy mediated by methylene blue and potassium iodide to treat urinary tract infection in a female rat model
  478. Antimicrobial photodynamic inactivation is potentiated by the addition of selenocyanate: Possible involvement of selenocyanogen?
  479. Flexible quantum dot light-emitting devices for targeted photomedical applications
  480. Current and Future Trends in Adipose Stem Cell Differentiation into Neuroglia
  481. Corrigendum to “Disinfection and healing effects of 222-nm UVC light on methicillin-resistant Staphylococcus aureus infection in mouse wounds” [J. Photochem. Photobiol. B Biol. 178 (January 2018) 10–18]
  482. Outstanding Reviewers for Photochemical and Photobiological Sciences in 2017
  483. Photobiomodulation and Cancer: What Is the Truth?
  484. Treatment of atrophic acne scarring with fractional micro-plasma radio-frequency in Chinese patients: A prospective study
  485. Options and Limitations in Clinical Investigation of Bacterial Biofilms
  486. Construction and response of a highly granular scintillator-based electromagnetic calorimeter
  487. 1012 Examining Daytime Sleepiness, Sleep Apnea, and Cognitive Decline in a 2-year Longitudinal Sample of Cognitively Normal Elderly
  488. Remodeling of dermal collagen in photoaged skin using low-dose 5-aminolevulinic acid photodynamic therapy occurs via the transforming growth factor-β pathway
  489. Potentiation by potassium iodide using TPPS4 for antimicrobial photodynamic inactivation
  490. Transcranial near-infrared photobiomodulation attenuates memory impairment and hippocampal oxidative stress in sleep-deprived mice
  491. 5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: Series of ten cases
  492. End of life care and nursing satisfaction is enhanced by the implementation of a clinical information system based protocol
  493. Noble metal nanostructures in optical biosensors: Basics, and their introduction to anti-doping detection
  494. Aging of lymphoid organs: Can photobiomodulation reverse age‐associated thymic involution via stimulation of extrapineal melatonin synthesis and bone marrow stem cells?
  495. Potassium iodide potentiates antimicrobial photodynamic inactivation mediated by Rose Bengal: in vitro and in vivo studies
  496. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation
  497. Brain Photobiomodulation Therapy: a Narrative Review
  498. Optical assays based on colloidal inorganic nanoparticles
  499. Potentiation by potassium iodide reveals that the anionic porphyrin TPPS4 is a surprisingly effective photosensitizer for antimicrobial photodynamic inactivation
  500. Fullerenes as photosensitizers in photodynamic therapy: pros and cons
  501. Photobiomodulation: lasersvs.light emitting diodes?
  502. Progressive cationic functionalization of chlorin derivatives for antimicrobial photodynamic inactivation and related vancomycin conjugates
  503. Upconversion in photodynamic therapy: plumbing the depths
  504. Introduction
  505. Advances in nature-inspired nanomaterials
  506. Alopecia
  507. Aptamers and pathogen-based carriers
  508. Carbon-based nanomaterials
  509. Disinfection and healing effects of 222-nm UVC light on methicillin-resistant Staphylococcus aureus infection in mouse wounds
  510. Drug delivery approaches
  511. Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing
  512. Polymeric and hyper-branched nanoparticles and dendrimers
  513. Reply to the Letter to the Editor on “Effects of Light-Emitting Diode Therapy on Muscle Hypertrophy, Gene Expression, Performance, Damage, and Delayed-Onset Muscle Soreness
  514. Advances in Nanomaterials for Drug Delivery: Polymeric, nanocarbon and bio-inspired
  515. Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe
  516. Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications
  517. Methylene Blue and Hydrogen Peroxide for Photodynamic Inactivation in Root Canal - A New Protocol for Use in Endodontics
  518. Photobiomodulation for traumatic brain injury and stroke
  519. Antimicrobial blue light inactivation of pathogenic microbes: State of the art
  520. Potentiation of antimicrobial photodynamic inactivation by inorganic salts
  521. NLRP3 Inflammasome Mediates Dormant Neutrophil Recruitment following Sterile Lung Injury and Protects against Subsequent Bacterial Pneumonia in Mice
  522. Can regenerative medicine and nanotechnology combine to heal wounds? The search for the ideal wound dressing
  523. In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging
  524. Development of a Click Beetle Luciferase Reporter System for Enhanced Bioluminescence Imaging of Listeria monocytogenes: Analysis in Cell Culture and Murine Infection Models
  525. Carbon nanotubes in microfluidic lab-on-a-chip technology: current trends and future perspectives
  526. Photodynamic therapy in dermatology beyond non-melanoma cancer: An update
  527. Attaching the NorA Efflux Pump Inhibitor INF55 to Methylene Blue Enhances Antimicrobial Photodynamic Inactivation of Methicillin-Resistant Staphylococcus aureus in Vitro and in Vivo
  528. Red (660 nm) or near-infrared (810 nm) photobiomodulation stimulates, while blue (415 nm), green (540 nm) light inhibits proliferation in human adipose-derived stem cells
  529. Advances in antimicrobial photodynamic inactivation at the nanoscale
  530. Non-invasive three-dimensional imaging of Escherichia coli K1 infection using diffuse light imaging tomography combined with micro-computed tomography
  531. Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report
  532. Zinc phthalocyanines attached to gold nanorods for simultaneous hyperthermic and photodynamic therapies against melanoma in vitro
  533. Visible Blue Light is Capable of Inactivating Candida albicans and Other Fungal Species
  534. Photobiomodulation of breast and cervical cancer stem cells using low-intensity laser irradiation
  535. Photobiomodulation leads to enhanced radiosensitivity through induction of apoptosis and autophagy in human cervical cancer cells
  536. Biological effects and medical applications of infrared radiation
  537. 380. Transcranial Photobiomodulation for Brain Disorders
  538. 383. Transcranial plus Intranasal Photobiomodulation in Mild to Moderately-Severe Dementia
  539. <em>In Vivo</em> Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant <em>Acinetobacter baumannii</em> Burn Infections Using Bioluminescence Imaging
  540. Potassium Iodide Potentiates Antimicrobial Photodynamic Inactivation Mediated by Rose Bengal in In Vitro and In Vivo Studies
  541. Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems
  542. Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL
  543. Strategies to potentiate immune response after photodynamic therapy (Conference Presentation)
  544. MP23-18 SYNERGISTIC PHOTODYNAMIC THERAPY FOR CATHETER-ASSOCIATED URINARY TRACT INFECTION IN RATS
  545. Type I and Type II Photosensitized Oxidation Reactions: Guidelines and Mechanistic Pathways
  546. Aus- und Weiterbildung
  547. Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light
  548. Management of Hypertension Using Olmesartan Alone or in Combination
  549. ROS generation and DNA damage with photo-inactivation mediated by silver nanoparticles in lung cancer cell line
  550. Mechanisms and Effects of Transcranial Direct Current Stimulation
  551. Quantum dot light emitting devices for photomedical applications
  552. Can microbial cells develop resistance to oxidative stress in antimicrobial photodynamic inactivation?
  553. Terahertz Spectroscopy to Determine Cold Shock Protein Stability Upon Solvation and Evaporation—A Molecular Dynamics Study
  554. Combinatory antibiotic therapy increases rate of bacterial kill but not final outcome in a novel mouse model of Staphylococcus aureus spinal implant infection
  555. Potassium Iodide Potentiates Broad-Spectrum Antimicrobial Photodynamic Inactivation Using Photofrin
  556. Infrared radiative properties and thermal modeling of ceramic-embedded textile fabrics
  557. Photobiomodulation of human adipose-derived stem cells using 810 nm and 980 nm lasers operates via different mechanisms of action
  558. Design features for optimization of tetrapyrrole macrocycles as antimicrobial and anticancer photosensitizers
  559. Photoantimicrobials—are we afraid of the light?
  560. Preclinical Evaluation of Photoacoustic Imaging as a Novel Noninvasive Approach to Detect an Orthopaedic Implant Infection
  561. Antimicrobial Blue Light Therapy for Infectious Keratitis: Ex Vivo and In Vivo Studies
  562. Surface-initiated polymerization with poly(n-hexylisocyanate) to covalently functionalize silica nanoparticles
  563. N-dihydrogalactochitosan as a potent immune activator for dendritic cells
  564. Noble metal nanoparticles in biosensors: recent studies and applications
  565. Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger
  566. Facial Manifestations of Pachydermoperiostosis Treated with Botulinum Toxin Type-A: Report of 3 Cases
  567. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation
  568. Photobiomodulation and Other Light Stimulation Procedures
  569. Photobiomodulation for Stroke
  570. Photomedicine and Stem Cells: The Janus face of photodynamic therapy (PDT) to kill cancer stem cells, and photobiomodulation (PBM) to stimulate normal stem cells
  571. Sonodynamic inactivation of Gram-positive and Gram-negative bacteria using a Rose Bengal–antimicrobial peptide conjugate
  572. Ultraviolet Irradiation of Blood: “The Cure That Time Forgot”?
  573. Photobiomodulation and the brain: a new paradigm
  574. Sodium ascorbate kills Candida albicans in vitro via iron-catalyzed Fenton reaction: importance of oxygenation and metabolism
  575. Photobiomodulation or low-level laser therapy
  576. Shining light on the head: Photobiomodulation for brain disorders
  577. Transcranial Low-Level Laser (Light) Therapy for Brain Injury
  578. Transcranial, Red/Near-Infrared Light-Emitting Diode Therapy to Improve Cognition in Chronic Traumatic Brain Injury
  579. Photobiomodulation in human muscle tissue: an advantage in sports performance?
  580. The application of antimicrobial photodynamic therapy (aPDT) in dentistry: a critical review
  581. Redox-Sensitive Smart Nanosystems for Drug and Gene Delivery
  582. Accelerated wound healing in a diabetic rat model using decellularized dermal matrix and human umbilical cord perivascular cells
  583. Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos
  584. Low-level laser therapy (904nm) can increase collagen and reduce oxidative and nitrosative stress in diabetic wounded mouse skin
  585. A Study of Physical and Mechanical Properties of the Indian Coconut for Efficient Dehusking
  586. Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes
  587. Use of fluorescent probes for ROS to tease apart Type I and Type II photochemical pathways in photodynamic therapy
  588. Effects of Light-Emitting Diode Therapy on Muscle Hypertrophy, Gene Expression, Performance, Damage, and Delayed-Onset Muscle Soreness
  589. Surface-initiated ring-opening metathesis polymerization (SI-ROMP) to attach a tethered organic corona onto CdSe/ZnS core/shell quantum dots
  590. Photobiomodulation (blue and green light) encourages osteoblastic-differentiation of human adipose-derived stem cells: role of intracellular calcium and light-gated ion channels
  591. Papain gel containing methylene blue for simultaneous caries removal and antimicrobial photoinactivation against Streptococcus mutans biofilms
  592. Temperature-Responsive Smart Nanocarriers for Delivery Of Therapeutic Agents: Applications and Recent Advances
  593. Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy
  594. Design, construction and commissioning of the Digital Hadron Calorimeter—DHCAL
  595. Light-emitting diode therapy in exercise-trained mice increases muscle performance, cytochrome c oxidase activity, ATP and cell proliferation [J. Biophotonics 8, No. 9, 740-754 (2015)]
  596. Broad-Spectrum Antimicrobial Effects of Photocatalysis Using Titanium Dioxide Nanoparticles Are Strongly Potentiated by Addition of Potassium Iodide
  597. The optical properties of mouse skin in the visible and near infrared spectral regions
  598. Virulence profile: Michael R. Hamblin
  599. Albumin nanostructures as advanced drug delivery systems
  600. Photodynamic therapy of oral Candida infection in a mouse model
  601. Broad-spectrum antimicrobial photocatalysis mediated by titanium dioxide and UVA is potentiated by addition of bromide ion via formation of hypobromite
  602. Low-level laser therapy stimulates the oxidative burst in human neutrophils and increases their fungicidal capacity
  603. DHCAL with minimal absorber: measurements with positrons
  604. Novel in vivo mouse model of implant related spine infection
  605. Structural and Kinetic Studies of Formate Dehydrogenase from Candida boidinii
  606. 274 A comparison of two new techniques for bacterial collection in cellulitis
  607. Malignant Glomus Tumor Arising in a Long Standing Precursor Lesion
  608. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy
  609. That bloody so-and-so has retired: Expressives revisited
  610. The effect of low level laser therapy on ventilator-induced lung injury in mice (Conference Presentation)
  611. Ultraviolet blood irradiation: Is it time to remember “the cure that time forgot”?
  612. Antimicrobial Photodynamic Inactivation and Antitumor Photodynamic Therapy with Fullerenes
  613. Errata: Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate
  614. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols
  615. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations
  616. Repeated transcranial low‐level laser therapy for traumatic brain injury in mice: biphasic dose response and long‐term treatment outcome
  617. Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis
  618. Application of Fluorescent Protein Expressing Strains to Evaluation of Anti-Tuberculosis Therapeutic Efficacy In Vitro and In Vivo
  619. Nanotechnology in diagnosis and treatment of coronary artery disease
  620. Antimicrobial blue light inactivation ofCandida albicans:In vitroandin vivostudies
  621. Endogenous Antimicrobial Photosensitization
  622. Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies
  623. New photosensitizers for photodynamic therapy
  624. The Effect of Protein Mass Modulation on Human Dihydrofolate Reductase
  625. Infrared and skin: Friend or foe
  626. Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate
  627. pH ‐Sensitive stimulus‐responsive nanocarriers for targeted delivery of therapeutic agents
  628. Smart mesoporous silica nanoparticles for controlled-release drug delivery
  629. Antibiotic resistance for viral infections
  630. Conclusions
  631. Introduction
  632. Chemical modifications
  633. Examples of the synthesis of monocationic and polycationic fullerene derivativess
  634. Fullerenes
  635. Fullerenes as photosensitizers
  636. General aspects of photodynamic inactivation of bacteria
  637. In Vivo Bioluminescence Imaging of Intratumoral Bacteria
  638. In vitro anti-cancer PDT with fullerenes
  639. In vitro antimicrobial PDT with fullerenes
  640. In vivo PDT for cancer
  641. In vivo antimicorbial PDT with fullerenes
  642. Introduction to Imaging in Dermatology
  643. Microfluidic systems for stem cell-based neural tissue engineering
  644. Nanotechnology and regenerative therapeutics in plastic surgery: The next frontier
  645. Photo-induced charge transfer
  646. Photodynamic Therapy with Hexa(sulfo-n-butyl)[60]Fullerene Against Sarcoma In Vitro and In Vivo
  647. Photodynamic therapy
  648. Photosensitizer forumlations for fullerene-mediated PDT
  649. Resonant Energy Transfer
  650. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
  651. Nanobiomaterials in dentistry
  652. Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
  653. Shower development of particles with momenta from 15 GeV to 150 GeV in the CALICE scintillator-tungsten hadronic calorimeter
  654. Photobiomodulation with 660-nm and 780-nm laser on activated J774 macrophage-like cells: Effect on M1 inflammatory markers
  655. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
  656. Animal models for photodynamic therapy (PDT)
  657. Photodynamic Therapy with Water-Soluble Cationic Fullerene Derivatives
  658. Smart Internal Stimulus-Responsive Nanocarriers for Drug and Gene Delivery
  659. Photoactivation of ROS Production In Situ Transiently Activates Cell Proliferation in Mouse Skin and in the Hair Follicle Stem Cell Niche Promoting Hair Growth and Wound Healing
  660. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies
  661. Multi-Modal Imaging with a Toolbox of Influenza AReporter Viruses
  662. Development of a proton CT head scanner
  663. John Joseph Hamblin
  664. Eradication of multidrug-resistant pseudomonas biofilm with pulsed electric fields
  665. Testing hadronic interaction models using a highly granular silicon–tungsten calorimeter
  666. Traumatic Brain Injury: A Major Medical Problem That Could Be Treated Using Transcranial, Red/Near-Infrared LED Photobiomodulation
  667. The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy
  668. Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs
  669. RELATIONSHIP BETWEEN DRY MATTER AND RIPENING TIME IN 'HASS' AVOCADO
  670. Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging
  671. Antimicrobial Photosensitizers: Drug Discovery Under the Spotlight
  672. Targeted imaging of bacterial infections: advances, hurdles and hopes
  673. Bacterial Photodynamic Inactivation Mediated by Methylene Blue and Red Light Is Enhanced by Synergistic Effect of Potassium Iodide
  674. Stable Synthetic Bacteriochlorins: Potent Light-Activated Anti-Cancer Drugs
  675. Red/near-infrared light-emitting diode therapy for traumatic brain injury
  676. Antimicrobial blue light therapy forCandida albicansburn infection in mice
  677. Low-Level Light in Combination with Metabolic Modulators for Effective Therapy of Injured Brain
  678. Pion and proton showers in the CALICE scintillator-steel analogue hadron calorimeter
  679. Therapeutic Options and Emerging Alternatives for Multidrug Resistant Staphylococcal Infections
  680. Harnessing the Power of Light to Treat Staphylococcal Infections Focusing on MRSA
  681. Network of Remote and Local Protein Dynamics in Dihydrofolate Reductase Catalysis
  682. Strategies to potentiate immune response after photodynamic therapy
  683. Low level light in combination with metabolic modulators for effective therapy
  684. Transcranial low-level laser therapy increases memory, learning, neuroprogenitor cells, BDNF and synaptogenesis in mice with traumatic brain injury
  685. Low level laser (light) therapy and photobiomodulation: the path forward
  686. Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP
  687. Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies
  688. Light-emitting diode therapy (LEDT) before matches prevents increase in creatine kinase with a light dose response in volleyball players
  689. Time response of increases in ATP and muscle resistance to fatigue after low-level laser (light) therapy (LLLT) in mice
  690. Antimicrobial photodynamic therapy in dentistry
  691. Nerve repair by light
  692. Low-level Laser Therapy to the Mouse Femur Enhances the Fungicidal Response of Neutrophils against Paracoccidioides brasiliensis
  693. Drug discovery for alopecia: gone today, hair tomorrow
  694. Antimicrobial photodynamic inactivation with decacationic functionalized fullerenes: Oxygen-independent photokilling in presence of azide and new mechanistic insights
  695. Carbon nanotubes part II: a remarkable carrier for drug and gene delivery
  696. Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicle
  697. Muscular pre-conditioning using light-emitting diode therapy (LEDT) for high-intensity exercise: a randomized double-blind placebo-controlled trial with a single elite runner
  698. T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?
  699. Nanotechnology for photodynamic therapy: a perspective from the Laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School
  700. Introduction
  701. Biomolecule-sensitive nanocarriers
  702. Enzyme-responsive nanocarriers
  703. Skin Photoaging
  704. Nanoscopic Electrofocusing for Bio-Nanoelectronic Devices
  705. Dual/multi-stimuli-sensitive nanocarriers
  706. Future perspectives and the global drug delivery systems market
  707. Pulsed Electric Fields for Burn Wound Disinfection in a Murine Model
  708. Redox-responsive micro/nanocarriers
  709. pH-sensitive micro/nanocarriers
  710. Low-level Laser (Light) Therapy Increases Mitochondrial Membrane Potential and ATP Synthesis in C2C12 Myotubes with a Peak Response at 3-6 h
  711. Spirit 2: An NCRI Randomised Study Comparing Dasatinib with Imatinib in Patients with Newly Diagnosed CML
  712. Escherichia coli dihydrofolate reductase catalyzed proton and hydride transfers: Temporal order and the roles of Asp27 and Tyr100
  713. Stable synthetic mono-substituted cationic bacteriochlorins mediate selective broad-spectrum photoinactivation of drug-resistant pathogens at nanomolar concentrations
  714. Low-level laser irradiation promotes the proliferation and maturation of keratinocytes during epithelial wound repair
  715. Light-emitting diode therapy in exercise-trained mice increases muscle performance, cytochrome c oxidase activity, ATP and cell proliferation
  716. Photodynamic Therapy Combined with Terbinafine Against Chromoblastomycosis and the Effect of PDT on Fonsecaea monophora In Vitro
  717. Performance of the first prototype of the CALICE scintillator strip electromagnetic calorimeter
  718. Combined <em>In vivo</em> Optical and µCT Imaging to Monitor Infection, Inflammation, and Bone Anatomy in an Orthopaedic Implant Infection in Mice
  719. Transcranial low-level laser therapy enhances learning, memory, and neuroprogenitor cells after traumatic brain injury in mice
  720. Real-Time Bioluminescence Imaging of Mixed Mycobacterial Infections
  721. Pre-Conditioning with Low-Level Laser (Light) Therapy: Light before the Storm
  722. Low-level laser therapy for traumatic brain injury in mice increases brain derived neurotrophic factor (BDNF) and synaptogenesis
  723. Functionalized Fullerenes in Photodynamic Therapy
  724. Photodynamic Therapy: One Step Ahead with Self-Assembled Nanoparticles
  725. Protein motions and the activation of the CH bond catalyzed by dihydrofolate reductase
  726. Real-time evaluation of two light delivery systems for photodynamic disinfection of Candida albicans biofilm in curved root canals
  727. Treatment of patients with suspected brain tuberculoma before or without bacteriologic confirmation in endemic places: report of two cases
  728. Azithromycin inhibits nuclear factor‐κB activation during lung inflammation: an in vivo imaging study
  729. Building, testing and validating a set of home-made von Frey filaments: A precise, accurate and cost effective alternative for nociception assessment
  730. Theranostic tumor homing nanocarriers for the treatment of lung cancer
  731. α–Intercalated cells defend the urinary system from bacterial infection
  732. Significant Improvements in Cognitive Performance Post-Transcranial, Red/Near-Infrared Light-Emitting Diode Treatments in Chronic, Mild Traumatic Brain Injury: Open-Protocol Study
  733. Eradication of multidrug-resistant A. baumannii in burn wounds by antiseptic pulsed electric field
  734. AB0349 Significance of Positive Anti-Ccp Antibody and Development of Interstitial Lung Disease in Patients with and without Clinically Apparent Rheumatoid Arthritis
  735. Topical Antimicrobials for Burn Infections – An Update
  736. Photoactivation of Endogenous Latent Transforming Growth Factor–β1 Directs Dental Stem Cell Differentiation for Regeneration
  737. Low-Level Laser Therapy Effectively Prevents Secondary Brain Injury Induced by Immediate Early Responsive Gene X-1 Deficiency
  738. Transfusion of stored blood impairs host defenses against Gram‐negative pathogens in mice
  739. Opening Up the Optical Imaging Window Using Nano-Luciferin
  740. 5-Aza-2′-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy
  741. Photodynamic therapy with decacationic [60]fullerene monoadducts: Effect of a light absorbing electron-donor antenna and micellar formulation
  742. Physical energy for drug delivery; poration, concentration and activation
  743. Photoactivated rose bengal functionalized chitosan nanoparticles produce antibacterial/biofilm activity and stabilize dentin-collagen
  744. Microbiota of Human Breast Tissue
  745. Photodynamic therapy improves the ultraviolet-irradiated hairless mice skin
  746. Structure–function relationships of Nile blue (EtNBS) derivatives as antimicrobial photosensitizers
  747. Photodynamic therapy for melanoma: efficacy and immunologic effects
  748. Low-level light therapy (LLLT) for cosmetics and dermatology
  749. Combination Prophylactic Therapy with Rifampin Increases Efficacy against an Experimental Staphylococcus epidermidis Subcutaneous Implant-Related Infection
  750. Antimicrobial photodynamic therapy with decacationic monoadducts and bisadducts of [70]fullerene: in vitro and in vivo studies
  751. Extension and Limits of the Network of Coupled Motions Correlated to Hydride Transfer in Dihydrofolate Reductase
  752. Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study
  753. Combination ALA-PDT and ablative fractional Er:YAG laser (2,940 nm) on the treatment of severe acne
  754. Potentiation of photoinactivation of Gram-positive and Gram-negative bacteria mediated by six phenothiazinium dyes by addition of azide ion
  755. Clostridium difficileinfection: molecular pathogenesis and novel therapeutics
  756. Cutaneous Sporotrichosis Treated with Photodynamic Therapy: An in Vitro and in Vivo Study
  757. Conclusions and future directions
  758. Experimental methods and results for the nanoscopic lens
  759. Intense focused ultrasound
  760. Laser and light treatment for skin photoaging
  761. Low-level light therapy (LLLT)
  762. Minimal invasive treatment
  763. Conclusions
  764. Introduction
  765. Nanoscopic lens modeling
  766. Primary prevention for skin photoaging
  767. Radiofrequency technology
  768. Secondary prevention for skin photoaging
  769. Skin aging and photoaging
  770. The nanoscopic lens: new generation applications and future scope
  771. Theory of nanoparticles in the nanoscopic lens
  772. Antimicrobial Blue Light Therapy for Multidrug-Resistant Acinetobacter baumannii Infection in a Mouse Burn Model: Implications for Prophylaxis and Treatment of Combat-related Wound Infections
  773. Electroporation enhances antimicrobial photodynamic therapy mediated by the hydrophobic photosensitizer, hypericin
  774. Surface modification of a polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU) nanocomposite polymer as a stent coating for enhanced capture of endothelial progenitor cells
  775. Thiocyanate potentiates antimicrobial photodynamic therapy: In situ generation of the sulfur trioxide radical anion by singlet oxygen
  776. Preservation of Protein Dynamics in Dihydrofolate Reductase Evolution
  777. Use of optical imaging to progress novel therapeutics to the clinic
  778. Can biowarfare agents be defeated with light?
  779. Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond
  780. Blue Light Eliminates Community-Acquired Methicillin-ResistantStaphylococcus aureusin Infected Mouse Skin Abrasions
  781. Effects of Photodynamic Therapy on Gram-Positive and Gram-Negative Bacterial Biofilms by Bioluminescence Imaging and Scanning Electron Microscopic Analysis
  782. Perfusion Defatting at Subnormothermic Temperatures in Steatotic Rat Livers
  783. Low-level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro
  784. Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin
  785. Cyclic Tetrapyrroles in Photodynamic Therapy: The Chemistry of Porphyrins and Related Compounds in Medicine
  786. Synthesis of Decacationic C70 Bisadducts by Incorporating Covalently BoundElectron-Donors for Enhancement of Radical-Based Type-I PDT
  787. Disruptive innovations: new anti-infectives in the age of resistance
  788. Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond
  789. Selective photoinactivation of Candida albicans in the non-vertebrate host infection model Galleria mellonella
  790. Ultraviolet Radiation in Wound Care: Sterilization and Stimulation
  791. Photodynamic Therapy of Murine Mastocytoma Induces Specific Immune Responses against the Cancer/Testis Antigen P1A
  792. Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen
  793. Low-level laser therapy for spinal cord injury in rats: effects of polarization
  794. Track segments in hadronic showers in a highly granular scintillator-steel hadron calorimeter
  795. Shining light on nanotechnology to help repair and regeneration
  796. Low-level laser (light) therapy (LLLT) for treatment of hair loss
  797. 4D Multimodality Imaging of <em>Citrobacter rodentium</em> Infections in Mice
  798. Synthesis of Photoresponsive Dual NIR Two-Photon Absorptive [60]Fullerene Triads and Tetrads
  799. Linear and Nonlinear Optical Properties of Photoresponsive [60]Fullerene Hybrid Triads and Tetrads with Dual NIR Two-Photon Absorption Characteristics
  800. CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer
  801. Vancomycin-Rifampin Combination Therapy Has Enhanced Efficacy against an Experimental Staphylococcus aureus Prosthetic Joint Infection
  802. Corrigendum
  803. Low level laser therapy increases angiogenesis in a model of ischemic skin flap in rats mediated by VEGF, HIF-1α and MMP-2
  804. The biochemistry of the metabolic poison propionate 3-nitronate and its conjugate acid, 3-nitropropionate
  805. Validation of GEANT4 Monte Carlo models with a highly granular scintillator-steel hadron calorimeter
  806. Antimicrobial Photodynamic Therapy to Kill Gram-negative Bacteria
  807. Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection
  808. UV-absorbing bacteria in coral mucus and their response to simulated temperature elevations
  809. Low-level laser therapy for fat layer reduction: A comprehensive review
  810. Channelrhodopsins: visual regeneration and neural activation by a light switch
  811. Studies on fast triggering and high precision tracking with Resistive Plate Chambers
  812. Photoinduced electron-transfer mechanisms for radical-enhanced photodynamic therapy mediated by water-soluble decacationic C70 and C84O2 Fullerene Derivatives
  813. Synthesis of decacationic [60]fullerene decaiodides giving photoinduced production of superoxide radicals and effective PDT-mediation on antimicrobial photoinactivation
  814. Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy
  815. Effect of red and near-infrared wavelengths on low-level laser (light) therapy-induced healing of partial-thickness dermal abrasion in mice
  816. The novel albumin–chitosan core–shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation
  817. Decacationic [70]Fullerene Approach for Efficient Photokilling of Infectious Bacteria and Cancer Cells
  818. Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway
  819. Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation
  820. Transcranial low-level light therapy produces neuroprotection, neurogenesis and BDNF after TBI in mice
  821. Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles
  822. Photodynamic therapy stimulates anti-tumor immune response in mouse models: the role of regulatory Tcells, anti-tumor antibodies, and immune attacks on brain metastases
  823. Linezolid and Vancomycin Decrease the Therapeutic Effect of Methylene Blue-Photodynamic therapy in a Mouse Model of MRSA Bacterial Arthritis
  824. Photodynamic and Antibiotic Therapy Impair the Pathogenesis of Enterococcus faecium in a Whole Animal Insect Model
  825. Photochemical activation of TRPA1 channels in neurons and animals
  826. Molecular Electronic Tuning of Photosensitizers to Enhance Photodynamic Therapy: Synthetic Dicyanobacteriochlorins as a Case Study
  827. Effect of Virulence Factors on the Photodynamic Inactivation of Cryptococcus neoformans
  828. Animal models of skin disease for drug discovery
  829. Melanoma resistance to photodynamic therapy: new insights
  830. Transcranial Low-Level Laser Therapy Improves Neurological Performance in Traumatic Brain Injury in Mice: Effect of Treatment Repetition Regimen
  831. Can osteoarthritis be treated with light?
  832. Self-assembled liposomal nanoparticles in photodynamic therapy
  833. Synthesis and evaluation of cationic bacteriochlorin amphiphiles with effective in vitro photodynamic activity against cancer cells at low nanomolar concentration
  834. Low-level laser therapy (LLLT) reduces oxidative stress in primary cortical neurons in vitro
  835. Blue Light Rescues Mice from Potentially Fatal Pseudomonas aeruginosa Burn Infection: Efficacy, Safety, and Mechanism of Action
  836. Paradoxical potentiation of methylene blue-mediated antimicrobial photodynamic inactivation by sodium azide: Role of ambient oxygen and azide radicals
  837. Low-level laser therapy (LLLT) combined with swimming training improved the lipid profile in rats fed with high-fat diet
  838. Antimicrobial Photodynamic Inactivation Inhibits Candida albicans Virulence Factors and ReducesIn VivoPathogenicity
  839. Bioluminescent Bacterial Imaging <em>In Vivo</em>
  840. Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity
  841. Monitoring Bacterial Burden, Inflammation and Bone Damage Longitudinally Using Optical and μCT Imaging in an Orthopaedic Implant Infection in Mice
  842. Killing Bacterial Spores with Blue Light: When Innate Resistance Meets the Power of Light
  843. Stable Synthetic Bacteriochlorins for Photodynamic Therapy: Role of Dicyano Peripheral Groups, Central Metal Substitution (2H, Zn, Pd), and Cremophor EL Delivery
  844. Improved Language after Scalp Application of Red/Near-Infrared Light-Emitting Diodes: Pilot Study supporting a New, Noninvasive Treatment for Chronic Aphasia
  845. Hadronic energy resolution of a highly granular scintillator-steel hadron calorimeter using software compensation techniques
  846. Low-level laser therapy (808 nm) reduces inflammatory response and oxidative stress in rat tibialis anterior muscle after cryolesion
  847. Bacterial vectors for imaging and cancer gene therapy: a review
  848. Antimicrobial photodynamic therapy with RLP068 kills methicillin-resistantStaphylococcus aureusand improves wound healing in a mouse model of infected skin abrasion PDT with RLP068/Cl in infected mouse skin abrasion
  849. Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle
  850. Ultraviolet C light for Acinetobacter baumannii wound infections in mice
  851. Photodynamic Therapy for Cancer and for Infections: What Is the Difference?
  852. Low-level laser therapy (808 nm) contributes to muscle regeneration and prevents fibrosis in rat tibialis anterior muscle after cryolesion
  853. Acute and Impaired Wound Healing
  854. Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?
  855. Chitosan dressing promotes healing in third degree burns in mice: Gene expression analysis shows biphasic effects for rapid tissue regeneration and decreased fibrotic signaling
  856. Transcranial low level laser (light) therapy for traumatic brain injury
  857. Characterization of a Conjugate between Rose Bengal and Chitosan for Targeted Antibiofilm and Tissue Stabilization Effects as a Potential Treatment of Infected Dentin
  858. Type I and Type II mechanisms of antimicrobial photodynamic therapy: An in vitro study on gram-negative and gram-positive bacteria
  859. Acute and Impaired Wound Healing
  860. Photodynamic therapy induces an immune response against a bacterial pathogen
  861. Shivajiella indica gen. nov., sp. nov., a marine bacterium of the family “Cyclobacteriaceae” with nitrate reducing activity
  862. Surface layer-preserving photodynamic therapy (SPPDT) in a subcutaneous mouse model of lung cancer
  863. Photodynamic Therapy Can Induce a Protective Innate Immune Response against Murine Bacterial Arthritis via Neutrophil Accumulation
  864. UVC Light Prophylaxis for Cutaneous Wound Infections in Mice
  865. Synthesis and Characterization of Positively Charged Pentacationic [60]Fullerene Monoadducts for Antimicrobial Photodynamic Inactivation
  866. A novel activity for fungal nitronate monooxygenase: Detoxification of the metabolic inhibitor propionate-3-nitronate
  867. Construction and performance of a silicon photomultiplier/extruded scintillator tail-catcher and muon-tracker
  868. Synthesis and Photodynamic Effect of New Highly Photostable Decacationically Armed [60]- and [70]Fullerene Decaiodide Monoadducts To Target Pathogenic Bacteria and Cancer Cells
  869. Antimicrobial Photodynamic Therapy and Photodynamic Inactivation, or Killing Bugs with Dyes and Light-A Symposium-in-Print
  870. In Vivo Optical Imaging in Gene & Cell Therapy
  871. Abstract 382: In-vivo imaging of lung cancer using tumor homing peptide coated nanoparticles
  872. Low level laser therapy reduces oxidative stress in cortical neurons in vitro
  873. Effects of polarization in low-level laser therapy of spinal cord injury in rats
  874. In vivo studies of low level laser (light) therapy for traumatic brain injury
  875. Photodynamic therapy with hyperbranched poly(ether-ester) chlorin(e6) nanoparticles on human tongue carcinoma CAL-27 cells
  876. Can nanotechnology potentiate photodynamic therapy?
  877. Glutathione Reductase Facilitates Host Defense by Sustaining Phagocytic Oxidative Burst and Promoting the Development of Neutrophil Extracellular Traps
  878. Daptomycin and Tigecycline Have Broader Effective Dose Ranges than Vancomycin as Prophylaxis against a Staphylococcus aureus Surgical Implant Infection in Mice
  879. Human Platelet-Rich Plasma- and Extracellular Matrix-Derived Peptides Promote Impaired Cutaneous Wound Healing In Vivo
  880. Strategies to Potentiate Antimicrobial Photoinactivation by Overcoming Resistant Phenotypes†
  881. Wound‐Healing Properties of Chitosan and Its Use in Wound Dressing Biopharmaceuticals
  882. Photodynamic therapy can induce non-specific protective immunity against a bacterial infection
  883. Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections?
  884. High Resolution In Vivo Bioluminescent Imaging for the Study of Bacterial Tumour Targeting
  885. Low-Level Laser Therapy for Closed-Head Traumatic Brain Injury in Mice: Effect of Different Wavelengths
  886. A renaissance in low-level laser (light) therapy – LLLT
  887. Concepts and Principles of Photodynamic Therapy as an Alternative Antifungal Discovery Platform
  888. Far infrared radiation (FIR): Its biological effects and medical applications
  889. Gram-Negative Bacterial Infection in Thigh Abscess Can Migrate to Distant Burn Depending on Burn Depth
  890. Low intensity laser therapy accelerates muscle regeneration in aged rats
  891. Low-level laser (light) therapy (LLLT) on muscle tissue: performance, fatigue and repair benefited by the power of light
  892. Multi-Functionality in Theranostic Nanoparticles: is more Always Better?
  893. Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma
  894. Photodynamic therapy with fullerenes in vivo: reality or a dream?
  895. Beam tests of directly coupled scintillator tiles with MPPC readout
  896. The Nuts and Bolts of Low-level Laser (Light) Therapy
  897. All you need is light
  898. Optimal Photosensitizers for Photodynamic Therapy of Infections Should Kill Bacteria but Spare Neutrophils
  899. Down‐regulation of glutatione S‐transferase α 4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection
  900. Photodynamic Therapy: Photosensitizer Targeting and Delivery
  901. Comparison of Therapeutic Effects between Pulsed and Continuous Wave 810-nm Wavelength Laser Irradiation for Traumatic Brain Injury in Mice
  902. Long-term monitoring of live cell proliferation in presence of PVP-Hypericin: a new strategy using ms pulses of LED and the fluorescent dye CFSE
  903. Effects of high-energy particle showers on the embedded front-end electronics of an electromagnetic calorimeter for a future lepton collider
  904. Production and commissioning of a large prototype Digital Hadron Calorimeter for future colliding beam experiments
  905. Imaging Pulmonary NF-kappaB Activation and Therapeutic Effects of MLN120B and TDZD-8
  906. Blue Dye and Red Light, a Dynamic Combination for Prophylaxis and Treatment of Cutaneous Candida albicans Infections in Mice
  907. Biphasic Dose Response in Low Level Light Therapy – an Update
  908. Dose response effects of 810 nm laser light on mouse primary cortical neurons
  909. Reply to “Championing photoantimicrobial discovery”
  910. Photodynamic therapy for infections: Clinical applications
  911. Mouse model of chronic post-arthroplasty infection: Noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study
  912. Low-Level Laser Therapy Activates NF-kB via Generation of Reactive Oxygen Species in Mouse Embryonic Fibroblasts
  913. Tests of a Particle Flow Algorithm with CALICE test beam data
  914. Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects
  915. Potential for Transcranial Laser or LED Therapy to Treat Stroke, Traumatic Brain Injury, and Neurodegenerative Disease
  916. Animal models of external traumatic wound infections
  917. Low Level Laser and Light Therapy
  918. Cell Death Pathways in Photodynamic Therapy of Cancer
  919. Effects of 810-nm Laser on Murine Bone-Marrow-Derived Dendritic Cells
  920. Antimicrobial photodynamic therapy: Can resistance develop?
  921. Photodynamic therapy of cancer: An update
  922. Combination approaches to potentiate immune response after photodynamic therapy for cancer
  923. The immunosuppressive side of PDT
  924. Drug Discovery of Antimicrobial Photosensitizers Using Animal Models
  925. Improved Cognitive Function After Transcranial, Light-Emitting Diode Treatments in Chronic, Traumatic Brain Injury: Two Case Reports
  926. Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans
  927. Synergistic Combination of Chitosan Acetate with Nanoparticle Silver as a Topical Antimicrobial: Efficacy against Bacterial Burn Infections
  928. Antimicrobial Photodynamic Therapy in the Colon: Delivering a Light Punch to the Guts?
  929. Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria
  930. Electromagnetic response of a highly granular hadronic calorimeter
  931. Antimicrobial mechanisms behind photodynamic effect in the presence of hydrogen peroxide
  932. Photodynamic inactivation of bacteria using polyethylenimine-chlorin(e6) conjugates: Effect of polymer molecular weight, substitution ratio of chlorin(e6) and pH
  933. Protective role of IL-1β against post-arthroplasty Staphylococcus aureus infection
  934. Photodynamic therapy using intra-articular photofrin for murine MRSA arthritis: Biphasic light dose response for neutrophil-mediated antibacterial effect
  935. Analysis of the Bacterial Heat Shock Response to Photodynamic Therapy-mediated Oxidative Stress
  936. Effects of 810 nm laser on mouse primary cortical neurons
  937. Oxidative stress of photodynamic antimicrobial chemotherapy inhibits Candida albicans virulence
  938. The potential role of functional inhibition of T regulatory cells by anti-TGFβ antibody in photodynamic therapy of renal cancer
  939. Ultraviolet-C Light for Treatment of Candida albicans Burn Infection in Mice
  940. Cryptococcus neoformans capsule protects cell from oxygen reactive species generated by antimicrobial photodynamic inactivation
  941. American Society for Laser Medicine and Surgery Abstracts
  942. Working model of an atomic force microscope
  943. Photodynamic Inactivation of Microbial Pathogens
  944. Antimicrobial Photodynamic Therapy with Functionalized Fullerenes: Quantitative Structure-activity Relationships
  945. Stimulation of anti-tumor immunity by photodynamic therapy
  946. Contents
  947. Dedication
  948. Front Matter
  949. Subject Index
  950. Volume Preface
  951. Therapeutic applications of light: PDT - the killer; LLLT - the healer
  952. Visualization of plant viral suppressor silencing activity in intact leaf lamina by quantitative fluorescent imaging
  953. Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response
  954. Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections
  955. Role of Low‐Level Laser Therapy in Neurorehabilitation
  956. In vivo sodium concentration continuously monitored with fluorescent sensors
  957. Ultraviolet-C Irradiation for Prevention of Central Venous Catheter-related Infections: An In Vitro Study
  958. FACTORS AFFECTING THE INCIDENCE OF 'RUSSET BROWNING' DISORDER IN 'COX'S ORANGE PIPPIN' APPLES
  959. Cationic Porphycenes as Potential Photosensitizers for Antimicrobial Photodynamic Therapy
  960. Efflux Pump Inhibitor Potentiates Antimicrobial Photodynamic Inactivation of Enterococcus faecalis Biofilm
  961. Corrigendum: Pentalysine β-Carbonylphthalocyanine Zinc: An Effective Tumor-Targeting Photosensitizer for Photodynamic Therapy
  962. The risk of biomaterial-associated infection after revision surgery due to an experimental primary implant infection
  963. Effect of pulsing in low-level light therapy
  964. Introduction to experimental and clinical studies using low-level Laser (light) therapy (LLLT)
  965. Stable Synthetic Cationic Bacteriochlorins as Selective Antimicrobial Photosensitizers
  966. Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: In vitro and in vivo studies
  967. Topical Antimicrobials for Burn Wound Infections
  968. Can surgical site infections be treated by photodynamic therapy?
  969. Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials
  970. Evaluating the surface density and heterogeneity of a dithiobis (succinimidylpropionate) self-assembled monolayer on gold and its coupling with DNA embedded within a matrix
  971. In Vitro Photodynamic Therapy and Quantitative Structure−Activity Relationship Studies with Stable Synthetic Near-Infrared-Absorbing Bacteriochlorin Photosensitizers
  972. Study of the interactions of pions in the CALICE silicon-tungsten calorimeter prototype
  973. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation
  974. The shortage of medical oncologists and low chemotherapy utilization in Australia.
  975. Advances in Low-Intensity Laser and Phototherapy
  976. Low-Level Laser Therapy in Stroke and Central Nervous System
  977. Pentalysine β-Carbonylphthalocyanine Zinc: An Effective Tumor-Targeting Photosensitizer for Photodynamic Therapy
  978. Construction and commissioning of the CALICE analog hadron calorimeter prototype
  979. Amorphous Basophilic Deposit in the Superficial Dermis of the Lip in an 80 Year Old
  980. Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy
  981. Protective effects of Red/Near Infrared Radiation on Murine Cardiac Ischemia/Reperfusion Injury
  982. Fluorescent Nano-Optodes for Glucose Detection
  983. Low level laser therapy for traumatic brain injury
  984. Can dendritic cells see light?
  985. Comparison of cellular responses induced by low level light in different cell types
  986. Front Matter for Volume 7552
  987. Photodynamic therapy for cancer and activation of immune response
  988. Transcranial LED therapy for cognitive dysfunction in chronic, mild traumatic brain injury: two case reports
  989. Book Review
  990. Characterization of Plant-Derived Saponin Natural Products against Candida albicans
  991. Synthesis and characterization of highly photoresponsive fullerenyl dyads with a close chromophore antenna–C60 contact and effective photodynamic potential

Showing 1,000 Stories.